Evaluation of the efficacy and toxicity of N-methyl-glucamine vs BP88® sodium stibogluconate in the treatment of localized cutaneous leishmaniasis;Avaliação comparativa da eficácia e toxicidade do antimoniato de N-metil-glucamina e do estibogluconato de sódio BP88® no tratamento da leishmaniose cutânea localizada

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 33, Issue 6, 2000, Pages 535-543

  Deps, Patrícia D ^a,b,d   Viana, Maria Carmen ^a,c   Falqueto, Aloísio ^a   Dietze, Reynaldo ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b Sch Med S Casa Misericordia V   (Brazil)

^c Departamento de Medicina Social EMESCAN   (Brazil)

^d NONE   (Brazil)

Author keywords

BP88 sodium stibogluconate; Cutaneous leishmaniasis; Efficacy; Glucantime ; Randomized clinical trial; Treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMYLASE; ASPARTATE AMINOTRANSFERASE; BP 88; CREATININE; MEGLUMINE ANTIMONATE; STIBOGLUCONATE SODIUM; TRIACYLGLYCEROL LIPASE; UREA; ANTIMONY GLUCONATE; ANTIPROTOZOAL AGENT; MEGLUMINE; MEGLUMINE ANTIMONIATE; ORGANOMETALLIC COMPOUND;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAM; FEMALE; HUMAN; INFANT; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SINGLE BLIND PROCEDURE; SKIN LEISHMANIASIS; COMPARATIVE STUDY; MIDDLE AGED;

ADOLESCENT; ADULT; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; CHILD; FEMALE; HUMANS; LEISHMANIASIS, CUTANEOUS; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; SINGLE-BLIND METHOD;

EID: 0034486514     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0037-86822000000600004     Document Type: Article

References (15)

1. Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years
2. Severe arthralgia, not related to dose, associated with pentavalent antimonial therapy for mucosal leishmaniasis
3. Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumina antimoniate
4. Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate)
5. Tratamento da leishmaniose tegumentar americana pelo antimoniato de N-metio-glucamina: Estudo duplo-cego com doses de 14mg/kg/dia e 28mg/kg/dia de antimônio
6. Estudo comparativo das alterações electrocardiográficas determinadas pelo tratamento com antimoniais tri e pentavalentes
7. Evolução eletrocardiográfica de pacientes tratados com antimoniais trivalentes e pentavalentes
8. High continuous antimony therapy in two patients with unresponsive mucosal leishmaniasis
9. Electrocardiographic changes during low-dose, short-term therapy of cutaneous leishmaniasis with the pentavalent antimonial meglumine
10. Avaliação da terapia com antimoniato de N-metil-glucamina e de notificação de leishmaniose tegumentar
11. Estudo comparativo entre estibogluconato de sódio e o antimoniato de meglumina no tratamento da leishmaniose cutânea: I. Eficácia e segurança
12. Avaliação do tratamento da leishmaniose cutâneo-mucosa com três esquemas diferentes de antimoniais pentavalentes
13. A cluster of cases of severe cardiotoxicity among kala-azar patients treated with a high-osmolarity lot of sodium antimony gluconate
14. The Leishmaniases
15. Control of the Leishmaniases